First postpartum depression pill now available in the US, drugmakers say wtva.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wtva.com Daily Mail and Mail on Sunday newspapers.
SPOKANE — A new drug treating postpartum depression was approved earlier this month by the Food and Drug Administration — possibly filling a gap in care, depending on the drug’s
Potential growth catalysts include planned 4Q 2023 launch of ZURZUVAE and expected data read-outs for SAGE-718 and SAGE-324 in 2024
Approximately 40% workforce reduction supports focus on agile.
SAGE Therapeutics (SAGE) Implements Strategic Reorganization to Support Plans for ZURZUVAE Commercial Launch streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.